endTB organization | endTB

PIH and PIH-affiliated clinicians discuss the case of the first patient in Kazakhstan to receive a new treatment regimen that includes Bedaquiline. (Photo by Askar Yedilbayev / Partners In Health) — PIH and PIH-affiliated clinicians discuss the case of the first patient in Kazakhstan to receive a new treatment regimen that includes Bedaquiline. (Photo by Askar Yedilbayev / Partners In Health)

Project Leaders

Dr. Aamir Khan (Interactive Research & Development)
Dr. Michael Rich (Partners In Health)
Dr. KJ Seung (Partners In Health)
Dr. Francis Varaine (Médecins Sans Frontières)

For bios of the endTB project leaders, see the Leadership page.

Observational Study (Output 1)

Principal Investigators

Dr. Helena Huerga (Epicentre)
Dr. Uzma Khan (Interactive Research & Development)
Dr. KJ Seung (Partners In Health)

First Clinical Trial (Output 2)

Principal Investigators

Dr. Carole Mitnick (Harvard Medical School)
Dr. Lorenzo Guglielmetti (Médecins sans Frontières)

Co-Investigators

Elisabeth Baudin (Epicentre)
Dr. Maryline Bonnet (Epicentre)
Dr. Bouke de Jong (Antwerp Institute of Tropical Medicine)
Dr. Michael Rich (Partners In Health)
Dr. Alex Telnov (Médecins sans Frontières)
Dr. Francis Varaine (Médecins sans Frontières)
Dr. Gabriella Ferlazzo (Médecins sans Frontières)
Dr. Gustavo Velásquez (Harvard Medical School)

Second Clinical Trial (Output 5)

Principal investigators

Dr. Carole Mitnick (Harvard Medical School)
Dr. Lorenzo Guglielmetti, MD (Médecins Sans Frontières)

Co-investigators

Dr. Maryline Bonnet (Epicentre)
Elisabeth Baudin (Epicentre)
Dr. Michael Rich (Partners In Health),
Dr. Kwonjune Seung (Partners In Health)
Dr. Gustavo Velásquez (Harvard Medical School)
Dr. Alex Telnov (Médecins Sans Frontières)
Dr. Gabriella Ferlazzo (Médecins Sans Frontières)
Dr. Bouke de Jong (Institute of Tropical Medicine),
Dr. Uzma Khan (Interactive Research & Development)
Dr. Francis Varaine (Médecins Sans Frontières)

PIH

UNITAID